Improvement of Work Productivity and Quality of Life With Anti-TNF Therapies Used in Crohn's Disease in Routing Clinical Practice in Turkey
Inclusion Criteria:
- Male or female patients between 18-65 years of age with moderately/severely (Crohn's
Disease Activity Index 220-450) active Crohn's disease with/without fistula
formation,
- Patients who are able to provide authorization to use and disclose information
related with the study,
- Proven diagnosis of Crohn's Disease in accordance with international diagnostic
criteria such as European Crohn's and Colitis Organisation (ECCO) guidelines,
- Patients for whom the physician has initiated Crohn's disease treatment with
anti-Tumor Necrosis Factors in accordance with Turkish Ministry of Health regulations
and reimbursements.
Exclusion Criteria:
- Subject has a history of any kind of biological therapy and/or anti-Tumor Necrosis
Factor treatments for Crohn's disease or other indications
- Subject has septic complications (active infection and/or active Tuberculosis,
undrained abscess),
- Patients who have bowel obstructions and fibrotic strictures,
- Subject has received any investigational drug within 30 days prior to the Visit 1 at
baseline,
- For any reason, subject is considered by the investigator to be an unsuitable.